Background The rationale behind this update of the 2016 British Society for Rheumatology
(BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …

Background & Aims The management of inflammatory bowel disease (IBD) poses a
particular challenge during pregnancy because the health of both the mother and the fetus …

A European League Against Rheumatism (EULAR) task force was established to define
points to consider on use of antirheumatic drugs before pregnancy, and during pregnancy …

Julia Flint1, Sonia Panchal2, Alice Hurrell3, Maud van de Venne4, Mary Gayed5, Karen
Schreiber6, 7, Subha Arthanari8, Joel Cunningham3, Lucy Flanders3, Louise Moore9, Amy …

Rheumatoid Arthritis (RA) is a chronic inflammatory disease characterized by a
heterogeneous clinical response to the different treatments. Some patients are difficult to …

Immunosuppressive drugs are used in the treatment of inflammatory and autoimmune
diseases, as well as in transplantation. Frequently prescribed in young people, these …

Inflammatory bowel disease (IBD) has a peak age of diagnosis before the age of 35 years.
Concerns about infertility, adverse pregnancy outcomes, and heritability of IBD have …

Infertility consists by definition in” failure to achieve a clinical pregnancy after 12 months or
more of regular unprotected intercourse” while the term subfertility means a delay to achieve …

Objectives Analyze the cumulative evidence for pregnancy outcomes after maternal
exposure to tocilizumab, an anti-interleukin-6-receptor monoclonal antibody used for the …

Introduction Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid
arthritis (RA), and is being investigated for the treatment of psoriasis. Both conditions can …